Table I.

Effects of gAPN on pulmonary oxygenation.

Group	T0	T1	T2	T3
NS	349.7500±34.70339	276.1667±18.21378	321.2083±33.45647	347.6250±39.13430
NIR	340.2500±69.56634	202.0417±17.91188a	242.2500±37.09144a	234.1250±8.93833a
NIRA	341.6667±43.32974	188.7083±28.02294a	298.6667±48.61443b	357.2500±57.97111b
DS	379.5000±38.02828	241.8833±21.36227a–c	298.6667±48.61443a,b	291.9583±54.47715b
DIR	331.3333±67.44992	161.8917±39.01699a,b,d	192.2500±22.51777a–d	168.7917±22.67235a–d
DIRA	396.9167±100.8507	159.7083±37.90957a,d,e	236.3333±28.56075a,c,d,e	217.2500±42.53528a,c,d,e

T₀-T₃ represent the following time points: Baseline, the end of ischemia, 120 min, and 240 min following reperfusion, respectively. PaO₂/FiO₂, partial pressure of arterial oxygen (PaO₂)/fraction of inspired oxygen (FiO₂). Results are expressed as the mean ± standard deviation (n=6).

^aP<0.05 vs. NS group

^bP<0.05 vs. NIR group

^cP<0.05 vs. NIRA group

^dP<0.05 vs. DS group

^eP<0.05 vs. DIR group. DIR, diabetic I/R group, in which the lung was subjected to 90 min of ischemia and 4 h of reperfusion; DIRA, diabetic I/R + gAPN group, in which 10 µg gAPN was injected 10 min prior reperfusion; DS, diabetic sham group, in which the left lung hilum was not clamped; NIR, I/R, in which the lung was subjected to 90 min of ischemia and 4 h of reperfusion; NIRA, I/R + gAPN, in which 10 µg gAPN was injected 10 min prior to reperfusion; NS, Sham group, in which the left lung hilum was not clamped. I/R, ischemia/reperfusion; gAPN, adiponectin globular domain.